ArticleActa pharmaceutica (Zagreb, Croatia)2022

AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells.

Octavio Galindo-Hernández et al.PubMed ↗Publisher ↗

No numbers read from the abstract.